Global Biofeedback Measurement Instrument Market, by Type (Brainwaves, Heart Rate, Muscles, Sweat Glands, and Others), by End User (Hospitals, Clinics, Home Settings, and Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), was valued at US$ 148.68 million in 2019, and is expected to exhibit a CAGR of 6.2% over the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights.
Biofeedback is the use of electronic or electromechanical equipment (usually computer-based) that helps to measure and provide feedback about physiological processes. The aim of biofeedback is to make patients aware about the different states of physiologic arousal and patients’ ability to control physiologic changes in their bodies. Goals of biofeedback treatment also includes improvement of the pediatric patient's ability to distinguish and cultivate lower levels of sympathetic nervous system arousal and achieve a balanced state of mind-body.
The increasing incidence of neurological disorders is expected to propel growth of the market during the forecast period. For instance, according to a report published by the World Health Organization (WHO) in 2016, there are 7.7 million new cases of dementia every year across the globe. Moreover, Alzheimer’s disease, which is the most common cause of dementia, accounts for 60 to 70% of dementia cases. Furthermore, according to the Mindgardens Neuroscience Network, the leading cause of disability in Australia in 2017 was mental and neurological disorders, which accounted for 20.5% of the total Australian daily adjusted life years (DALYs).
Browse 20 Market Data Tables and 16 Figures spread through 150 Pages and in-depth TOC on “Biofeedback Measurement Instrument Market” - Global forecast to 2027, by Type (Brainwaves, Heart Rate, Muscles, Sweat Glands, and Others), by End User (Hospitals, Clinics, Home Settings, and Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
To know the latest trends and insights prevalent in the Biofeedback Measurement Instrument Market, click the link below:
Asia Pacific is expected to offer lucrative growth opportunities for players operating in the biofeedback measurement instrument market owing to the rising incidence of CNS disorders in the region. For instance, according to an article published by the National Center for Biotechnology Information (NCBI), in 2018 reports that the burden of dementia in Japan is growing and it is expected that 1 in 5 elderly people will suffer from dementia in Japan by 2025.
Moreover, the growing patient pool with neurological disorders in this region is expected to drive growth of the market during the forecast period. For instance, according to the Mindgardens Neuroscience Network, in 2017, the total prevalence of neurological disorders in Australia was 10.6 million (43.0%), followed by 4 million (16.3%) for mental health disorders, and 0.8 million (3.2.0%) for substance disorders.
Key Takeaways of the Biofeedback Measurement Instrument Market: